Hillsdale Investment Management’s Boston Scientific BSX Stock Holding History

Hillsdale Investment Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$637K	Buy	10,150 +1,500	+17%	+$120K	0.02%	415
2025 Q4	$825K	Buy	8,650 +100	+1%	+$9.8K	0.02%	411
2025 Q3	$835K	Buy	8,550 +1,600	+23%	+$166K	0.03%	397
2025 Q2	$747K	Buy	6,950 +900	+15%	+$91.1K	0.03%	350
2025 Q1	$610K	Sell	6,050 -2,450	-29%	-$247K	0.03%	337
2024 Q4	$759K	Buy	+8,500	New	+$748K	0.04%	293
2023 Q4	–	Sell	-10,400	Closed	-$549K	–	575
2023 Q3	$549K	Buy	10,400 +1,700	+20%	+$89.2K	0.05%	239
2023 Q2	$471K	Buy	+8,700	New	+$454K	0.04%	253

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hillsdale Investment Management's BSX Position: Q1 2026 in Review

Hillsdale Investment Management increased its Boston Scientific (BSX) stake by 17% in Q1 2026, buying an estimated $120K and bringing the position to 10,150 shares worth $637K. The position accounts for 0.02% of the portfolio, ranked #415.

Hillsdale Investment Management first reported a position in BSX in Q2 2023 and has held it in 8 quarters since. The position peaked at $835K in Q3 2025. 1,672 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Hillsdale Investment Management held 10,150 shares of Boston Scientific worth $637K as of Q1 2026.
Hillsdale Investment Management bought 1,500 Boston Scientific shares in Q1 2026, an estimated $120K.
Boston Scientific made up 0.02% of Hillsdale Investment Management's portfolio in Q1 2026, its #415 holding.
Hillsdale Investment Management first reported a position in Boston Scientific in Q2 2023 and has held it in 8 quarters since.
Hillsdale Investment Management's Boston Scientific position peaked at $835K in Q3 2025.
1,672 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Hillsdale Investment Management's 13F filing for Q1 2026, filed 4 May 2026.